indobufen has been researched along with arachidonic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagiwara, M; Hidaka, H; Ishikawa, T; Mamiya, S | 1 |
| Bergamaschi, M; Branzoli, U; Pierucci, L | 1 |
| Choi, HI; Lee, JY; Sung, KC | 1 |
3 other study(ies) available for indobufen and arachidonic acid
| Article | Year |
|---|---|
Specific inhibition of 40 K protein phosphorylation in platelet by a new antithrombotic agent, d-indobufen.
Topics: Adenosine Triphosphate; Adult; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Collagen; Humans; Indomethacin; Isoindoles; Molecular Weight; Phenylbutyrates; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase Inhibitors; Thrombin | 1989 |
Inhibitory activity of indobufen (*) on platelet aggregation in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Depression, Chemical; Isoindoles; Lethal Dose 50; Male; Mice; Phenylbutyrates; Platelet Aggregation | 1984 |
Comparison of aspirin and indobufen in healthy volunteers.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Arachidonic Acid; Aspirin; Blood Platelets; Cross-Over Studies; Drug Administration Schedule; Female; Healthy Volunteers; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prostaglandin-Endoperoxide Synthases; Thromboxane B2 | 2016 |